Document is current

Any future updates will be listed below

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s40360-017-0175-0

Published Online: 2017-10-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark